Join ACC's Prevention of Cardiovascular Disease Member Section's Leadership Council on Tuesday, Dec. 1 at 1 p.m. ET for a conversation with Steven E. Nissen, MD, MACC, and Paul M. Ridker, MD, MPH, FACC, exploring their late-breaking clinical trials presented at AHA 2026. Hear about the trials' key findings, their implications for clinical practice and practical takeaways for patient care, followed by a live audience Q&A. Learn more and register. Visit ACC's meeting coverage page for full coverage of AHA 2026.